KB Home’s built-to-order model delivers higher margins. However, a strong shift to BTO brings risks as backlog orders decline ...

KB Home faces weakening demand, margin compression, discounting of high-cost inventory, and worsening guidance after Q4 2025.

Discover key takeaways from KB Home's Q4 2025 earnings call—insights on BTO strategy, margin outlook, and 2026 revenue guidance.

KB Home’s fourth quarter was met with a negative market reaction, as the company faced a sharp decline in year-over-year sales and reduced operating margins. Management cited persistent affordability ...

Keefe Bruyette analyst Jade Rahmani lowered the firm’s price target on KB Home (KBH) to $62 from $67. The firm keeps a Market Perform rating on ...

KB Home’s housing deliveries decreased 9% to 3,619 homes, while the average selling price fell 7% to $465,600 compared to the year-ago period. The company’s homebuilding operating income margin ...

KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

For almost 21 years, KB Glutathione plus NAC + KB Rosehips Vitamin C has been a pioneering combination in the glutathione category. From its origin with the first manufacturer, production moved to ...